Navidea Biopharmaceutical Stock (OTC:NAVB), Quotes and News Summary

Q: What sector and industry does Navidea Biopharmaceutical (NAVB) operate in?

Navidea Biopharmaceutical is in the Health Care sector and Biotechnology industry. They are listed on the OTCPK.

Navidea Biopharmaceutical Stock (OTC: NAVB) stock price, news, charts, stock research, profile.

Open	$0.037
Close	$0.038
Volume / Avg.	3.138K / 109.868K
Day Range	0.037 - 0.038
52 Wk Range	0.021 - 0.276
Market Cap	$3.753M
P/E Ratio	-
Dividend Yield	-
Exchange	OTC
RSI	0
Short Interest	-
Days to Cover	2.95

Recent News

Why Femasys Shares Are Trading Higher By Over 200%; Here Are 20 Stocks Moving Premarket

Gainers Femasys Inc. (NASDAQ: FEMY) shares rose 201% to $1.00 in pre-market trading after the company received FDA 510(k) clearance for FemaSeed, an infertility treatment.

Lisa Levin

Why Terran Orbital Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Gainers Connexa Sports Technologies Inc. (NASDAQ: CNXA) shares jumped 124.2% to $0.1697 after falling 15% on Monday.

Lisa Levin

Why Eiger BioPharmaceuticals Shares Are Trading Lower By 52%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Gainers Avalo Therapeutics, Inc. (NASDAQ: AVTX) shares surged 68% to $0.2075. Avalo Therapeutics, on Sept 12, got notice from the Nasdaq as of Sept 11 the company’s securities had closing bid price of $0.10/less for 10 consecutive trading days.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

About Navidea Biopharmaceuticals Inc

Sector

Health Care

Industry

Biotechnology

Navidea Biopharmaceuticals Inc is a biotechnology company specializied in precision medicine. Its pr...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Navidea Biopharmaceutical (NAVB) stock?

You can purchase shares of Navidea Biopharmaceutical (OTCPK: NAVB) through any online brokerage.

View our list of the best stock brokerages.

Who are Navidea Biopharmaceutical's (NAVB) competitors?

There are no as such competitors for Navidea Biopharmaceutical.

What is the target price for Navidea Biopharmaceutical (NAVB) stock?

The latest price target for Navidea Biopharmaceutical (OTCPK: NAVB) was reported by HC Wainwright & Co. on Monday, August 17, 2020. The analyst firm set a price target for 8.00 expecting NAVB to rise to within 12 months (a possible 21233.33% upside). 0 analyst firms have reported ratings in the last year.

Current Stock Price for Navidea Biopharmaceutical (NAVB)?

The stock price for Navidea Biopharmaceutical (OTCPK: NAVB) is $0.0375 last updated Today at April 24, 2024 at 4:00 PM EDT.

Does Navidea Biopharmaceutical (NAVB) pay a dividend?

There are no upcoming dividends for Navidea Biopharmaceutical.

When is Navidea Biopharmaceutical (OTCPK:NAVB) reporting earnings?

Navidea Biopharmaceutical’s Q1 earnings are confirmed for Thursday, May 9, 2024.

Is Navidea Biopharmaceutical (NAVB) going to split?

There is no upcoming split for Navidea Biopharmaceutical.

What sector and industry does Navidea Biopharmaceutical (NAVB) operate in?

Navidea Biopharmaceutical is in the Health Care sector and Biotechnology industry. They are listed on the OTCPK.